MRK Total Non-Current Assets

Merck & Co. · Total Non-Current Assets

MRK logo

MRK Total Non-Current Assets

Latest reported$93.12B
MRK Quarterly Non-Current Assets ($2.59B → $93.12B)
High-resolution chart · PNG

MRK total non-current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. Total Non-Current Assets — Quarterly (USD)
Period endingTotal Non-Current Assets (USD)
93,123,000,000
93,670,000,000
93,350,000,000
81,989,000,000
80,458,000,000
79,619,000,000
78,324,000,000
77,171,000,000
74,425,000,000
74,404,000,000
74,507,000,000
74,773,000,000
74,492,000,000
74,394,000,000
73,438,000,000
73,520,000,000
74,979,000,000
75,484,000,000
75,428,000,000
62,436,000,000
62,023,000,000
63,938,000,000
63,824,000,000
63,223,000,000
61,272,000,000
58,739,000,000
56,914,000,000
57,189,000,000
59,667,000,000
57,003,000,000
56,762,000,000
58,294,000,000
60,976,000,000
61,956,000,000
63,106,000,000
63,757,000,000
64,637,000,000
65,031,000,000
64,763,000,000
68,895,000,000
68,549,000,000
69,983,000,000
71,926,000,000
72,665,000,000
74,263,000,000
75,418,000,000
65,562,000,000
67,085,000,000
64,273,000,000
67,220,000,000
69,960,000,000
68,654,000,000
69,881,000,000
70,956,000,000
71,275,000,000
70,072,000,000
69,886,000,000
71,165,000,000
71,947,000,000
72,425,000,000
73,827,000,000
74,841,000,000
76,717,000,000
80,084,000,000
79,916,900,000
83,348,900,000
83,882,000,000
19,070,600,000
20,173,200,000
20,358,500,000
28,083,100,000
29,127,200,000
29,864,600,000
29,994,100,000
33,305,300,000
31,537,000,000
31,747,100,000
31,250,800,000
29,339,600,000
28,494,900,000
27,588,600,000
25,406,100,000
23,796,500,000
23,765,700,000
23,877,000,000
27,357,100,000
29,097,600,000
29,014,000,000
28,566,200,000
28,703,900,000
29,060,300,000
28,567,800,000
33,705,100,000
33,572,600,000
33,174,800,000
33,313,800,000
32,655,500,000
31,450,700,000
31,059,600,000
29,782,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.